compounding pharmacy glp-1 fda enforcement news today New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our GLP-1 Medications – FDA Guidance

The once-weekly injection schedule is both sufficient for maintaining therapeutic levels and the only regimen with clinical safety data supporting it

Scrutinizing authenticity documentation remains crucial regardless of the supplier chosen

Frequent side effects include gastrointestinal symptoms, such as nausea, vomiting, diarrhea or obstipation

Focus on Niche Markets: Some 503B facilities specialize in producing niche or customized medications, including GLP-1s

81900726 belonging to Xue Zhao)

"Sesames unique model allows us not only to make high-quality specialty care like weight loss much more accessible and affordable, but also to empower clinicians to create care plans that are specific toand appropriate foreach individual patient." New York City-based Sesame launched in 2019 to connect patients to in-person and virtual care using a direct-pay model